# A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing

> **NCT05857930** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **OM Pharma SA** · enrollment: 296 (actual)

## Conditions studied

- Recurrent Wheezing
- Wheezing Lower Respiratory Illness

## Interventions

- **DRUG:** OM-85
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05857930
- **Lead sponsor:** OM Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-20
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 296 (ACTUAL)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05857930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05857930, "A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children With Recurrent Wheezing". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05857930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*